The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
CONTEXT: Mutations have been identified in the aryl hydrocarbon receptor-interacting protein (AIP) gene in familial isolated pituitary adenomas (FIPA). It is not clear, however, how this molecular chaperone is involved in tumorigenesis. OBJECTIVE: AIP sequence changes and expression were studied in FIPA and sporadic adenomas. The function of normal and mutated AIP molecules was studied on cell proliferation and protein-protein interaction. Cellular and ultrastructural AIP localization was determined in pituitary cells. PATIENTS: Twenty-six FIPA kindreds and 85 sporadic pituitary adenoma patients were included in the study. RESULTS: Nine families harbored AIP mutations. Overexpression of wild-type AIP in TIG3 and HEK293 human fibroblast and GH3 pituitary cell lines dramatically reduced cell proliferation, whereas mutant AIP lost this ability. All the mutations led to a disruption of the protein-protein interaction between AIP and phosphodiesterase-4A5. In normal pituitary, AIP colocalizes exclusively with GH and prolactin, and it is found in association with the secretory vesicle, as shown by double-immunofluorescence and electron microscopy staining. In sporadic pituitary adenomas, however, AIP is expressed in all tumor types. In addition, whereas AIP is expressed in the secretory vesicle in GH-secreting tumors, similar to normal GH-secreting cells, in lactotroph, corticotroph, and nonfunctioning adenomas, it is localized to the cytoplasm and not in the secretory vesicles. CONCLUSIONS: Our functional evaluation of AIP mutations is consistent with a tumor-suppressor role for AIP and its involvement in familial acromegaly. The abnormal expression and subcellular localization of AIP in sporadic pituitary adenomas indicate deranged regulation of this protein during tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
The pathogenesis of pituitary tumours
Asa, S. L., & Ezzat, S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc926 · Cited by 435
Carver, L. A., & Bradfield, C. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11452 · Cited by 416
Daly, A. F., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2513 · Cited by 326
RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription
Vogel, C. F. A., Sciullo, E., Li, W., Wong, P., Lazennec, G., & Matsumura, F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0211 · Cited by 319
Cozzi, R., Montini, M., Attanasio, R., Albizzi, M., Lasio, G., Lodrini, S., Doneda, P., Cortesi, L., & Pagani, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2347 · Cited by 228
Zudaire, E., Cuesta, N., Murty, V., Woodson, K., Adams, L., Gonzalez, N., Martínez, A., Narayan, G., Kirsch, I., Franklin, W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci30024 · Cited by 211
Binding of Aryl Hydrocarbon Receptor (AhR) to AhR-interacting Protein
Bell, D. R., & Poland, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004236200 · Cited by 180
Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303269200 · Cited by 168
Self-citationde Oliveira, S. K., Hoffmeister, M., Gambaryan, S. P., Müller‐Esterl, W., Guimarães, J. A., & Smolenski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610942200 · Cited by 125
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation
Kuzhandaivelu, N. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.23.4741 · Cited by 123
[The pituitary and hormonal calcium regulation system].
Salzer, G. M. (1971) · PubMed · Cited by 120
Cazabat, L., Libé, R., Perlemoine, K., René-Corail, F., Burnichon, N., Gimenez‐Roqueplo, A., Pasquier-Fediaevsky, L. D., BERTAGNA, X. Y., Clauser, É., Chanson, P., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0181 · Cited by 114
Petrulis, J. R., Hord, N. G., & Perdew, G. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006873200 · Cited by 111
AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins
Yano, M., Terada, K., & Mori, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305051 · Cited by 107
Iwata, T., Yamada, S., Mizusawa, N., Golam, H. M., Sano, T., & Yoshimoto, K. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02758.x · Cited by 99
Self-citationNaves, L. A., Daly, A., Vanbellinghen, J.-F., Casulari, L. A., Spilioti, C., de Magalhães, A. V., Azevedo, M. F., Giacomini, L., Nascimento, P. P., Nunes, R. O., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0533 · Cited by 99
Regulation of Survivin Stability by the Aryl Hydrocarbon Receptor-interacting Protein
Kang, B. H., & Altieri, D. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603175200 · Cited by 95
Aryl Hydrocarbon Receptor Interacting Protein Variants in Sporadic Pituitary Adenomas
Yu, R., Bonert, V. S., Saporta, I., Raffel, L. J., & Melmed, S. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1731 · Cited by 67
Georgitsi, M., Karhu, A., Winqvist, R., Visakorpi, T., Waltering, K. K., Vahteristo, P., Launonen, V., & Aaltonen, L. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603573 · Cited by 65
Pollenz, R. S., & Dougherty, E. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506619200 · Cited by 59
Hollingshead, B. D., Petrulis, J. R., & Perdew, G. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407840200 · Cited by 55
Raitila, A., Georgitsi, M., Karhu, A., Tuppurainen, K., Mäkinen, M. J., Birkenkamp‐Demtröder, K., Salmenkivi, K., Orntoft, T. F., Arola, J. T., Launonen, V., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0025 · Cited by 55
Pollenz, R. S., Wilson, S. E., & Dougherty, E. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027672 · Cited by 49
Clerget-Froidevaux, M.-S., Berg, P., Seugnet, I., Decherf, S., Becker, N., Sachs, L. M., Bilesimo, P., Nygård, M., Pongratz, I., & DEMENEIX, B. A. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400778 · Cited by 47
A meiotic recombination in a new isolated familial somatotropinoma kindred
Luccio-Camelo, D., Une, K. N., Ferreira, R., Khoo, S., Nickolov, R. Z., Bronstein, M., Vaisman, M., Teh, B. T., La, F., Mendonca, B. B., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500643 · Cited by 43
Self-citationAIP Mutations are not Identified in Patients with Sporadic Pituitary Adenomas
DiGiovanni, R., Serra, S., Ezzat, S., & Asa, S. L. (2007) · Endocrine Pathology · doi:10.1007/s12022-007-0010-z · Cited by 32
Hollingshead, B. D., Patel, R. D., & Perdew, G. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029215 · Cited by 31
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Acromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
Pathogenesis of pituitary tumors
Melmed, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 466
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Houslay, M. D. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.007 · Cited by 430
Somatostatin receptors: From signaling to clinical practice
Theodoropoulou, M., & Stalla, G. K. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.07.005 · Cited by 410
Metadata
- Authors
- Leontiou, C. A., Gueorguiev, M., van der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H. S., Igreja, S. C., Jordan, S., Rowe, J., Stolbrink, M., Christian, H. C., Wray, J., Bishop-Bailey, D., Berney, D. M., Wass, J. A. H., Popovic, V., Ribeiro-Oliveira, A., Gadelha, M. R., Monson, J. P., Akker, S. A., Davis, J. R. E., Clayton, R. N., Yoshimoto, K., Iwata, T., Matsuno, A., Eguchi, K., Musat, M., Flanagan, D., Peters, G., Bolger, G. B., Chapple, J. P., Frohman, L. A., Grossman, A. B., & Korbonits, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-06-01
- Volume
- 93
- Issue
- 6
- Pages
- 2390-2401
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2054316167
- Cited by
- 299
- References
- 29
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.